Close Menu

Quanta BioSciences

The company is developing dedicated product lines for next-generation sequencing that incorporate a thermal cycler capable of 35-minute PCR.

NEW YORK (GenomeWeb) ― Tracking immunity and virus shedding after oral polio vaccination usually requires culture of poliovirus from stool samples.

NEW YORK (GenomeWeb) – An international team of academic and industry researchers this week published the results of a comparison of commercially available platforms for microRNA expression analysis, finding that each has its own strengths and shortcomings that should be considered before selecti

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has given 510(k) clearance to the CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel.

The University of Washington has been awarded US Patent No. 8,420,325, "Thermostable polymerases having altered fidelity and methods of identifying and using same."
Lawrence Loeb, Leroy Hood, and Motoshi Suzuki are named as inventors.

NEW YORK (GenomeWeb News) – ZyGem today said that it has entered into an agreement with Quanta BioSciences to incorporate its enzymatic RNA-extraction technology into Quanta's quantitative PCR reagent kits.

Corbett Life Science has been awarded US Patent No. 8,124,413, "Thermocycler and sample port."
Keith Stanley and John Corbett are named as inventors on the patent.

Patent watchdog firm Troll Busters has chosen to abandon its lawsuit against more than a dozen life science companies for false patent marking related to various nucleic acid detection, amplification, and cloning technologies, according to recently filed court documents.

A US district court has dismissed a lawsuit filed earlier this year against more than a dozen life science companies alleging that they falsely marked certain nucleic acid detection, amplification, and cloning technologies as being patented after the relevant patents expired.

IDT will produce the assays, which will allow scientists to detect and profile mature miRNA sequences; and will market them through an online catalog directly to customers of Quanta.

Pages

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.